Sacchetti et al (1999) Studies on the acute and chronic effects of reboxetine on extracellular noradrenaline and other monoamines in the rat brain. Br.J.Pharmacol. 128 1332. Wong et al (2000) Reboxetine: a pharmacologically potent, selective, and specific norepinephrine reuptake inhibitor. Biol.Psychiatry. 47 818. Millan et al (2001) S33005, a novel ligand at both serotonin and norepinephrine transporters: I. Receptor binding, electrophysiological, and neurochemical profile in comparison with venlafaxine, reboxetine, citalopram, and clomipramine. J.Pharmacol.Exp.Ther. 298 565. Owen and Whitton (2003) Reboxetine modulates norepinephrine efflux in the frontal cortex of the freely moving rat: the involvement of a2 and 5-HT1A receptors. Neurosci.Lett. 348 171.
의 억제제:
SLC6A2.
건강 상태 :
Solid
용해도 :
Soluble in water (82 mg/ml at 25° C), DMSO (82 mg/ml at 25° C), chloroform, methanol, and ethanol (<1 mg/ml at 25° C).